You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API neostigmine methylsulfate and glycopyrrolate

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing neostigmine methylsulfate and glycopyrrolate

Subscribe to access the full database, or Subscribe
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
PAR PHARMACEUTICAL INC	PREVDUO	neostigmine methylsulfate and glycopyrrolate	42023-269	EDETATE DISODIUM	2038-10-25
PAR PHARMACEUTICAL INC	PREVDUO	neostigmine methylsulfate and glycopyrrolate	42023-269	HYDROCHLORIC ACID	2038-10-25
PAR PHARMACEUTICAL INC	PREVDUO	neostigmine methylsulfate and glycopyrrolate	42023-269	NITROGEN	2038-10-25
PAR PHARMACEUTICAL INC	PREVDUO	neostigmine methylsulfate and glycopyrrolate	42023-269	SODIUM CHLORIDE	2038-10-25
PAR PHARMACEUTICAL INC	PREVDUO	neostigmine methylsulfate and glycopyrrolate	42023-269	SODIUM HYDROXIDE	2038-10-25
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for neostigmine methylsulfate and glycopyrrolate

Excipient focus: EDETATE DISODIUM

neostigmine methylsulfate and glycopyrrolate drug variants containing EDETATE DISODIUM

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
PAR PHARMACEUTICAL INC	neostigmine methylsulfate and glycopyrrolate	42023-269
>Company	>Ingredient	>NDC

neostigmine methylsulfate and glycopyrrolate drug variants not containing EDETATE DISODIUM

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROCHLORIC ACID

neostigmine methylsulfate and glycopyrrolate drug variants containing HYDROCHLORIC ACID

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
PAR PHARMACEUTICAL INC	neostigmine methylsulfate and glycopyrrolate	42023-269
>Company	>Ingredient	>NDC

neostigmine methylsulfate and glycopyrrolate drug variants not containing HYDROCHLORIC ACID

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: NITROGEN

neostigmine methylsulfate and glycopyrrolate drug variants containing NITROGEN

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
PAR PHARMACEUTICAL INC	neostigmine methylsulfate and glycopyrrolate	42023-269
>Company	>Ingredient	>NDC

neostigmine methylsulfate and glycopyrrolate drug variants not containing NITROGEN

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM CHLORIDE

neostigmine methylsulfate and glycopyrrolate drug variants containing SODIUM CHLORIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
PAR PHARMACEUTICAL INC	neostigmine methylsulfate and glycopyrrolate	42023-269
>Company	>Ingredient	>NDC

neostigmine methylsulfate and glycopyrrolate drug variants not containing SODIUM CHLORIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

neostigmine methylsulfate and glycopyrrolate drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
PAR PHARMACEUTICAL INC	neostigmine methylsulfate and glycopyrrolate	42023-269
>Company	>Ingredient	>NDC

neostigmine methylsulfate and glycopyrrolate drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

neostigmine methylsulfate and glycopyrrolate drug variants containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
PAR PHARMACEUTICAL INC	neostigmine methylsulfate and glycopyrrolate	42023-269
>Company	>Ingredient	>NDC

neostigmine methylsulfate and glycopyrrolate drug variants not containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.